Full video transcriptClick to expand
Auto-generated transcript of @glowconfranxu's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00We have been able to access the activity with a lot of other activities.
- 0:06We already had a lot of much of our own activity.
- 0:10We were able to look at the small and strong conditions for us.
- 0:16We are able toze the activity with a lot of people.
- 0:18I've created a lot of different activities that we haven't moved,
- 0:22and I'm still following it.
- 0:25We also have given this new approach to the formula that I used.
SYN-AKE peptide: does snake venom skincare actually work?
Quick answer
SYN-AKE (Dipeptide Diaminobutyroyl Benzylamide Diacetate) is a synthetic tripeptide that competitively and reversibly antagonizes nicotinic acetylcholine receptors at the neuromuscular junction, modeled on waglerin-1 from Tropidolaemus wagleri venom. Industry-funded trials suggest modest wrinkle reduction at 1-4% concentrations, but the 889 Da molecular weight raises legitimate questions about transdermal penetration without enhanced delivery systems. It is a cosmetic ingredient, not a drug, and its effects are not clinically equivalent to injectable neuromodulators.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 4 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For SYN-AKE peptide: does snake venom skincare actually work?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
SYN-AKE peptide: does snake venom skincare actually work? is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "SYN-AKE peptide: does snake venom skincare actually work?" from Franxu Díaz ✨ Skincare. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: SYN-AKE (Dipeptide Diaminobutyroyl Benzylamide Diacetate) is a synthetic tripeptide that competitively and reversibly antagonizes nicotinic acetylcholine receptors at the neuromuscular junction, modeled on waglerin-1 from Tropidolaemus wagleri venom.
The reason this review is not generic is the source wording and the canonical claim label "peptides veneno de serpiente en la piel syn ake o dipeptide diaminobu." In this clip, the useful excerpt is: "We have been able to access the activity with a lot of other activities." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging (2015), Effects of glycyl-histidyl-lysine-Cu on wound healing (Search), and Copper peptide and skin remodeling literature (Search), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
SYN-AKE (Dipeptide Diaminobutyroyl Benzylamide Diacetate) is a synthetic tripeptide that competitively and reversibly antagonizes nicotinic acetylcholine receptors at the neuromuscular junction, modeled on waglerin-1 from Tropidolaemus wagleri venom.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- SYN-AKE (Dipeptide Diaminobutyroyl Benzylamide Diacetate) is a synthetic tripeptide that competitively and reversibly antagonizes nicotinic acetylcholine receptors at the neuromuscular junction, modeled on waglerin-1 from Tropidolaemus wagleri venom. Industry-funded trials suggest modest wrinkle reduction at 1-4% concentrations, but the 889 Da molecular weight raises legitimate questions about transdermal penetration without enhanced delivery systems. It is a cosmetic ingredient, not a drug, and its effects are not clinically equivalent to injectable neuromodulators.
- SYN-AKE has a molecular weight of approximately 889 Da, exceeding the widely cited 500 Da cutoff for passive transdermal penetration, which limits its efficacy without enhanced delivery systems.
- The only published clinical trials on SYN-AKE showing wrinkle reduction were conducted or funded by the ingredient manufacturer (Pentapharm/DSM), and independent replication is sparse as of 2024.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- SYN-AKE has a molecular weight of approximately 889 Da, exceeding the widely cited 500 Da cutoff for passive transdermal penetration, which limits its efficacy without enhanced delivery systems.
- The only published clinical trials on SYN-AKE showing wrinkle reduction were conducted or funded by the ingredient manufacturer (Pentapharm/DSM), and independent replication is sparse as of 2024.
- Waglerin-1, the natural peptide SYN-AKE is modeled on, does antagonize muscular nicotinic acetylcholine receptors. The mechanism is real; the question is whether enough topically applied peptide reaches those receptors.
- Injectable botulinum toxin and topical SYN-AKE work through entirely different mechanisms at different points in the neuromuscular junction. They are not clinically equivalent and should not be compared as alternatives.
- Argireline and SYN-AKE are frequently paired in product formulations and social media content but target different molecular pathways. Combining them is not harmful, but the marketing language around the combination is often imprecise.
- Cosmetic peptides in this category are generally low-risk for topical use, but 'low-risk' does not mean 'proven effective.' Consumers should weigh the often high price point against the current evidence base.
- If anti-aging outcomes are a health priority, a consultation with a board-certified dermatologist provides access to interventions with substantially stronger clinical evidence than any topical peptide currently available.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @glowconfranxu actually say?
Honestly, the transcript here is largely incoherent, likely the result of a failed auto-transcription from Spanish. What we can work with is the caption, which makes a specific and testable claim: SYN-AKE (Dipeptide Diaminobutyroyl Benzylamide Diacetate) is a synthetic peptide "inspired by" the venom of the snake Tropidolaemus wagleri, and it "mimics the effects of the venom to relax facial muscles," helping reduce wrinkles. That is actually a fairly precise claim about a real ingredient, and it deserves a real answer rather than a dismissal.
The creator is not inventing this. SYN-AKE is a registered trademarked peptide sold by DSM (now dsm-firmenich), and the snake venom connection is the company's own marketing framing. So the question is whether the framing is accurate, and whether the effect size is meaningful for consumers.
Does the science back this up?
Partially, but the evidence is thin and mostly industry-funded. The mechanism is plausible, but the clinical proof in humans is limited. SYN-AKE was designed to mimic waglerin-1, a peptide found in Tropidolaemus wagleri venom that acts as an antagonist at nicotinic acetylcholine receptors, particularly the muscular subtype. In theory, blocking those receptors at the neuromuscular junction reduces muscle contraction, which over time could soften expression lines.
A 2012 study published by DSM's own research team showed a statistically significant reduction in wrinkle depth after four weeks of topical application in a small cohort. However, independent replication is sparse. A review by Pai et al. (2017, Journal of Cosmetic Dermatology) noted that peptide penetration through intact skin remains the central unresolved problem for topinally applied neuromuscular peptides. The stratum corneum is not particularly interested in letting large peptide molecules through. SYN-AKE has a molecular weight of roughly 889 Da, which is above the commonly cited 500 Da cutoff for effective skin penetration. That does not make it useless, but it does mean the "relaxing muscles" story requires more scrutiny than a TikTok caption can provide.
What did they get wrong (or right)?
The creator got the origin story essentially right. SYN-AKE is genuinely modeled on waglerin-1 from Tropidolaemus wagleri, and the receptor mechanism described is consistent with published pharmacology. Credit where it is due.
Where things get shakier is the implied equivalence with Botox-level muscle relaxation. The hashtag "botox" in the caption signals a comparison that the data does not fully support. Botulinum toxin works by cleaving SNARE proteins inside the presynaptic nerve terminal, causing complete and prolonged blockade of acetylcholine release. SYN-AKE works on the receptor side, competitively and reversibly. These are fundamentally different mechanisms with very different potency profiles. Topically applied SYN-AKE does not produce the same depth or duration of neuromuscular effect as an injected neuromodulator. Framing them in the same breath is misleading to consumers who might use a serum instead of seeking a medical consultation for a condition that warrants one.
Argireline (Acetyl Hexapeptide-3) is also mentioned in the hashtags. That peptide targets the SNAP-25 protein in the SNARE complex, a different mechanism again. Lumping these together without explanation muddies what is actually an interesting distinction.
What should you actually know?
SYN-AKE is a legitimate cosmetic peptide with a coherent biological rationale. If you see it in a product at concentrations between 1% and 4% (the range used in most studies), it is not snake oil in the pejorative sense. The snake part is real; the oil part is still being worked out.
The honest summary is this: topical peptides in this class may produce modest, temporary improvements in the appearance of fine lines, particularly expression lines. They are not going to replicate the effect of a neuromodulator injection. The penetration problem is real, and the independent clinical evidence is not robust enough to call this category proven. Formulators are working on delivery systems, including liposomal encapsulation and microneedle patches, that could change this picture.
- If you are interested in anti-aging topicals, look for independent peer-reviewed data, not brand-sponsored trials.
- Peptide serums are generally low-risk, but they are also frequently overpriced relative to their demonstrated efficacy.
- If you have significant concerns about facial aging, a board-certified dermatologist is the appropriate resource, not a hashtag comparison to Botox.
Bottom line
The caption is more accurate than most TikTok skincare content. The mechanism described is real. The comparison to injectable neuromodulators implied by the hashtags is where the content oversells. SYN-AKE is an interesting ingredient with a plausible but not fully proven mechanism. Treat it as a cosmetic with modest potential, not a topical Botox.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Franxu Díaz ✨ Skincare · TikTok creator
19.8K views on this video
🐍¿VENENO de SERPIENTE en la PIEL?🐍 🫧 SYN-AKE o ✨Dipeptide Diaminobutyroyl Benzylamide Diacetate✨ es un péptido sintético inspirado en el veneno de la serpiente 🐍Tropidolaemus wagleri🐍 Este ingrediente revolucionario imita los efectos del veneno para relajar los músculos faciales, ayudando a reducir arrugas y líneas de expresión, proporcionando un efecto similar al botox pero sin inyecciones 💉❌ #skincare #antiarrugas #antiedad #synake #argireline #botox #peptide #consejosdebelleza
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about syn-ake has a molecular weight of approximately 889 da, exceeding?
SYN-AKE has a molecular weight of approximately 889 Da, exceeding the widely cited 500 Da cutoff for passive transdermal penetration, which limits its efficacy without enhanced delivery systems.
What does the video say about the only published clinical trials on syn-ake showing wrinkle reduction?
The only published clinical trials on SYN-AKE showing wrinkle reduction were conducted or funded by the ingredient manufacturer (Pentapharm/DSM), and independent replication is sparse as of 2024.
What does the video say about waglerin-1, the natural peptide syn-ake?
Waglerin-1, the natural peptide SYN-AKE is modeled on, does antagonize muscular nicotinic acetylcholine receptors. The mechanism is real; the question is whether enough topically applied peptide reaches those receptors.
What does the video say about injectable botulinum toxin?
Injectable botulinum toxin and topical SYN-AKE work through entirely different mechanisms at different points in the neuromuscular junction. They are not clinically equivalent and should not be compared as alternatives.
What does the video say about argireline?
Argireline and SYN-AKE are frequently paired in product formulations and social media content but target different molecular pathways. Combining them is not harmful, but the marketing language around the combination is often imprecise.
What does the video say about cosmetic peptides in this category?
Cosmetic peptides in this category are generally low-risk for topical use, but 'low-risk' does not mean 'proven effective.' Consumers should weigh the often high price point against the current evidence base.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Franxu Díaz ✨ Skincare, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.